Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Bibliographic Details
Main Authors:	Kim, Suzy, Oh, So Won, Kim, Jin Soo, Kim, Ki Hwan, Kim, Yu Kyeong
Format:	Online
Language:	English
Published:	The Korean Society for Radiation Oncology 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282997/

Similar Items

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
by: Enomoto, Keisuke, et al.
Published: (2009)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
by: Kwak, Yoo-Kang, et al.
Published: (2014)

Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
by: Kim, Hwan-Ik, et al.
Published: (2016)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
by: Lee, Kyong Joo, et al.
Published: (2013)

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
by: Topkan, Erkan, et al.
Published: (2011)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study
by: Choi, Younak, et al.
Published: (2016)

Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
by: Lee, Ik Jae, et al.
Published: (2014)

Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
by: Kang, Ki Mun, et al.
Published: (2012)

Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
by: Yoon, Hong In, et al.
Published: (2016)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
by: Kim, Yeon-Joo, et al.
Published: (2013)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
by: Kim, Young-Il, et al.
Published: (2013)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
by: Fukushima, Toshirou, et al.
Published: (2014)

Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
by: Yang, Jie, et al.
Published: (2016)

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
by: Kadkhodayan, Sima, et al.
Published: (2013)

The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer
by: Lee, Hyo Chun, et al.
Published: (2014)

Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution
by: Lee, Kyung Ha, et al.
Published: (2016)

18F-alfatide PET/CT may predict short-term outcome of concurrent chemoradiotherapy in patients with advanced non-small cell lung cancer
by: Luan, Xiaohui, et al.
Published: (2016)

Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer
by: Park, Young Hee, et al.
Published: (2013)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
by: HASEGAWA, MASAHIRO, et al.
Published: (2014)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
by: Lee, Joo Ho, et al.
Published: (2011)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
by: Day, F L, et al.
Published: (2011)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
by: Atsumi, Kazushige, et al.
Published: (2013)

A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer
by: Gupta, Arunima, et al.
Published: (2014)

Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
by: Zhang, Lijuan, et al.
Published: (2015)

Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer
by: Byun, Sang Jun, et al.
Published: (2015)

The Role of 18 F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy
by: Choi, Jiyoun, et al.
Published: (2013)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Travaini, Laura L, et al.
Published: (2016)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
by: Kong, Moonkyoo, et al.
Published: (2012)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
by: Lee, Sung Uk, et al.
Published: (2013)

Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Lee, Nam Kwon, et al.
Published: (2014)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
by: Noh, Jae Myoung, et al.
Published: (2015)

Combined pretreatment with 18F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial
by: Shengjun Ji, et al.
Published: (2018-08-01)

Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
by: Topkan, Erkan, et al.
Published: (2012)

Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies
by: Zhao, Jing, et al.
Published: (2016)

Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
by: Liu, Lipin, et al.
Published: (2015)

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
by: Bearz, Alessandra, et al.
Published: (2013)

The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy
by: Koo, Tae Ryool, et al.
Published: (2014)

18-FDG PET in lung transplantation
by: Algieri, I, et al.
Published: (2015)

Potential of 18F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
by: Choi, Noah C., et al.
Published: (2013)